Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 193111 | Remetinostat | 946150-57-8 | >98% |  |
| Remetinostat, also known as SHP-141, is a topical formulation containing the histone | ||||
| 19355 | RG7834 | 2072057-17-9 | >98% |  |
| RG7834，also known as RO7020322, is a novel oral HBV viral gene expression inhibitor | ||||
| 19353 | RWJ-56110 | 252889-88-6 | >98% |  |
| RWJ-56110 is a selective protease-activated receptor-1 (PAR1) antagonist. It blocks t | ||||
| 19313 | RBC8 | 361185-42-4 | >98% |  |
| RBC8 is a RalA and RalB GTPase inhibitor (EC50 ~3.5 μM). RBC8 suppresses growth of x | ||||
| 192277 | Rogaratinib | 1443530-05-9 | >98% |  |
| Rogaratinib, also known as BAY-1163877, is an aberrant fibroblast growth factor recep | ||||
| 192254 | Rebimastat | 259188-38-0 | >98% |  |
| Rebimastat, also known as BMS275291, is a sulfhydryl-based second-generation matrix m | ||||
| 192193 | Retosiban | 820957-38-8 | >98% |  |
| Retosiban, also known as GSK-221149-A; is an oral active, potent and selective, sub-n | ||||
| 19183 | RKI-1313 | 1342276-76-9 | >98% |  |
| RKI-1313 Negative control for RKI-1447 (GLXC-05200) which is a potent inhibitor of th | ||||
| 19181 | RGX-104 free form | 610318-54-2 | >98% |  |
| RGX-104, also known as SB 742881, is a liver X receptor beta agonist with potential i | ||||
| 1811151 | R547 | 741713-40-6 | >98% |  |
| R547 is orally bioavailable diaminopyrimidine cyclin-dependent kinase inhibitor (CDKI | ||||
| 1810224 | Regadenoson | 313348-27-5 | >98% |  |
| Regadenoson is an A2A adenosine receptor agonist that is a coronary vasodilator that | ||||
| 18751 | Resminostat | 864814-88-0 | >98% |  |
| Resminostat, also known as 4S-201 and RAS2410, is an orally bioavailable inhibitor of | ||||
| 186251 | RMC-4550 | 2172651-73-7 | >98% |  |
| RMC-4550 is a potent and selective SHP2 inhibitor. | ||||
| 186234 | RGX-104 HCl | 610318-03-1 | >98% |  |
| RGX-104 is a liver X receptor beta agonist with potential immunomodulating and antine | ||||
| 185317 | Resminostat HCl | 1187075-34-8 | >98% |  |
| Resminostat HCl is a potent inhibitor of HDAC1/3/6. | ||||
| 185234 | Rovazolac | 1454288-88-0 | >98% |  |
| Rovazolac is an anti-inflammatory drug candidate. | ||||
| 185152 | Rolapitant free base | 5552292-08-7 | >98% |  |
| Rolapitant, also known as SCH-619734, is an orally bioavailable, centrally-acting, se | ||||
| 185141 | RO10-5824 | 189744-46-5 | >98% |  |
| RO10-5824 is a D4-selective partial agonist. RO10-5824 is a potent candidate for the | ||||
| 184281 | Ricasetron | 117086-68-7 | >98% |  |
| Ricasetron, also known as Brl 46470, is antiemetic and axiolytic. | ||||
| 18413 | R-IMPP | 2133832-83-2 | >98% |  |
| R-IMPP is an inhibitor of PCSK9 translation. | ||||
| 18441 | Rimegepant | 1289023-67-1 | >98% |  |
| Rimegepant, aslo known as BMS-927711, is a potent, selective, competitive and orally | ||||
| 18435 | Ritlecitinib ( PF-06651600 ) | 1792180-81-4 | ≧98.0% |  |
| Ritlecitinib ( PF-06651600 ) is a potent and selective JAK3 inhibitor. PF-06651600, a | ||||
| 18432 | R-GNE-140 | 2003234-63-5 | >98% |  |
| R-GNE-140 a novel potent lactate dehydrogenase (LDHA) inhibitor with IC50 3nM for LDH | ||||
| 183217 | (2R,14R)-4-((R)-1-((R)-4-benzyl-2-oxooxazolidin-3-yl)-3-(tert-butoxycarbonyl)-1-oxopropan-2-yl)benzyl 2,4-dimethylbenzoate | 2097334-19-3 | >98% |  |
| (2R,14R)-4-((R)-1-((R)-4-benzyl-2-oxooxazolidin-3-yl)-3-(tert-butoxycarbonyl)-1-oxopr | ||||
| 183216 | (R)-4-(2-(4-benzyl-2-oxooxazolidin-3-yl)-2-oxoethyl)benzyl 2,4-dimethylbenzoate | 2097334-18-2 | >98% |  |
| (R)-4-(2-(4-benzyl-2-oxooxazolidin-3-yl)-2-oxoethyl)benzyl 2,4-dimethylbenzoate is a | ||||
| 1712156 | Relebactam | 1174018-99-5 | >98% |  |
| Relebactam,也称为MK- 7655,一个强有力的、具有选择性的β-lactamase抑制 | ||||
| 179137 | Rimonabant HCl | 158681-13-1 | 98.0% |  |
| Rimonabant, also known as SR141716, is an anorectic anti-obesity drug. It is an inver | ||||
| 179131 | Riviciclib HCl | 920113-03-7 | 98.0% |  |
| Riviciclib, also known as P276-00 , is a flavone and cyclin dependent kinase (CDK) in | ||||
| 17917 | RVT-501 | 947620-48-6 | 98.0% |  |
| RVT-501, also known as E-6005, is a phosphodiesterase 4 (PDE-4) inhibitor potentially | ||||
| 2017889 | Roluperidone ( CYR-101 ) | 359625-79-9 | 98.0% |  |
| Roluperidone, also known as MIN-101, CYR-101, and MT-210, is a 5-HT2A and sigma 2 rec | ||||